Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,869
Closed -$301K 364
2018
Q2
$301K Buy
+2,869
New +$289K 0.05% 301
2017
Q2
Sell
-21,277
Closed -$1.48M 849
2017
Q1
$1.48M Sell
21,277
-26,901
-56% -$1.86M 0.09% 335
2016
Q4
$3.25M Buy
+48,178
New +$3.27M 0.19% 169
2015
Q3
Sell
-19,972
Closed -$1.29M 827
2015
Q2
$1.29M Buy
+19,972
New +$1.35M 0.18% 166
2014
Q3
Sell
-9,718
Closed -$520K 473
2014
Q2
$520K Buy
+9,718
New +$500K 0.26% 115

Other funds holding STE

Clinton Group's STE Position: Q3 2018 in Review

Clinton Group sold out of Steris (STE) in Q3 2018, closing a stake of 2,869 shares — an estimated $301K sold.

Clinton Group first reported a position in STE in Q2 2014 and held it in 5 quarters. The position peaked at $3.25M in Q4 2016. 387 funds tracked by Wall St. Rank hold STE as of Q3 2018.

  • Clinton Group reported no remaining Steris position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 2,869 Steris shares in Q3 2018, an estimated $301K.
  • Clinton Group first reported a position in Steris in Q2 2014 and held it in 5 quarters.
  • Clinton Group's Steris position peaked at $3.25M in Q4 2016.
  • 387 funds tracked by Wall St. Rank held Steris as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.